Announced Wed, 15 Apr · 14:08 IST

Compliances - Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+3.5%1-day move

₹9.50

prior close

₹9.32

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.0+0.0+0.0+4.1+3.5-9.5—-3.5-4.2—-12.5-21.1-24.7-42.6

Up moveDown movePending

AI summary

Dipna Pharmachem Ltd submitted its quarterly compliance certificate under SEBI Regulation 74(5) for Q4 ending 31 March 2026. The filing, verified by RTA Bigshare Services Private Limited, confirms that no securities were received for dematerialization during the period 1 January 2026 to 31 March 2026. As a result, no share certificates were mutilated, cancelled, or substituted. This is a routine regulatory filing confirming normal share registry operations with no dematerialization activity during the quarter.

Likely market impact

No shareholder or stock price impact — this is a standard regulatory compliance confirmation with no material changes to share registry status.